Gerd‐Rüdiger Burmester
Humboldt-Universität zu Berlin(DE)Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, Autoimmune and Inflammatory Disorders Research, T-cell and B-cell Immunology
Most-Cited Works
- → 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative(2010)4,780 cited
- → Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks(2006)1,631 cited
- → Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial(2017)396 cited
- → Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trial(2003)392 cited
- → Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action(2004)365 cited